« Previous Next » The Journal of Allergy and Clinical Immunology
Volume 122, Issue 2 , Pages 342-347.e2 , August 2008

Tolerance to extensively heated milk in children with cow's milk allergy

Received 21 February 2008 ,Revised 27 May 2008 ,Accepted 30 May 2008.

Study design and enrollment. HM, Heated milk; OFC, oral food challenge; UHM, unheated milk.

Study design and enrollment. HM, Heated milk; OFC, oral food challenge; UHM, unheated milk.
- Full-Size Image
- Download to PowerPoint
Predicted probabilities of the heated milk challenge outcome in regard to milk-specific IgE and SPT. Logistic regression was used to calculate the probability of reacting during heated milk (HM) oral

Predicted probabilities of the heated milk challenge outcome in regard to milk-specific IgE and SPT. Logistic regression was used to calculate the probability of reacting during heated milk (HM) oral food challenge (OFC) in regard to serum milk-specific IgE antibody concentration and SPT wheal size.
- Full-Size Image
- Download to PowerPoint

H.A.S. is supported in part by NIH NIAID AI44236 and AI 066738. A.N.-W. is supported in part by NIH NIAID AI 059318. S.H.S. is supported in part by NIH NIAID AI 066738. W.G.S. is supported by NIH NIAID K08 AI067722. The project was supported in part by grant no. MO1-RR-00071 from the National Center for Research Resources, a component of the National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health.

Disclosure of potential conflict of interest: S. H. Sicherer has consulting arrangements with the Food Allergy Initiative; has received research support from the National Institutes of Health and the Food Allergy and Anaphylaxis Network; and is an advisor for the Food Allergy and Anaphylaxis Network. W. G. Shreffler has received research support from the National Institute of Allergy and Infectious Diseases and the Food Allergy Initiative. H. A. Sampson has consulting arrangements with Allertein Therapeutics; has received research support from the National Institutes of Health and the Food Allergy Initiative; and is an advisor for the Food Allergy and Anaphylaxis Network. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(08)01111-1

doi: 10.1016/j.jaci.2008.05.043

« Previous Next » The Journal of Allergy and Clinical Immunology
Volume 122, Issue 2 , Pages 342-347.e2 , August 2008